Downregulation of miR-22-3p observed in patients may lessen its inhibitory effects on targets like HIF-1α, promoting hypoxia, inflammation, angiogenesis, and endometrial proliferation—all central to endometriosis pathogenesis [43,44]. Here, HIF1A is linked to endometriosis.